Miyasaka Aki 宮坂亞希

Researcher Number	10754997
Affiliation (Current)	2021: 地方独立行政法人埼玉県立病院機構埼玉県立がんセンター(臨床腫瘍研究所), 病院婦人科, 医長
Affiliation (based on the past Project Information) *help	2018: 東京大学, 医学部附属病院, 登録研究員 2016 – 2017: 東京大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Obstetrics and gynecology / Tumor therapeutics
Keywords	Principal Investigator 子宮腫瘍 / クリニカルシークエンス / 相同組換修復 / PARP阻害薬 / 子宮体癌 / BRCA / MED1 / DNA修復 / 化学療法 / 放射線 … More

Development of therapeutics targeting DNA damage repair pathway in uterine neoplasmsPrincipal Investigator
- Principal Investigator
  
  Miyasaka Aki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
  Tumor therapeutics
- Research Institution
  The University of Tokyo

All 2019 2018

All Journal Article

[Journal Article] Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas2019
- Author(s)
  Kukita A, Sone K, Oda K, Hamamoto R, Kaneko S, Komatsu M, Wada M, Honjoh H, Kawata Y, Kojima M, Oki S, Sato M, Asada K, Taguchi A, Miyasaka A, Tanikawa M, Nagasaka K, Matsumoto Y, Wada-Hiraike O, Osuga Y, Fujii T
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: in press Pages: 340-346
- DOI
  10.1016/j.bbrc.2019.03.155
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K09249, KAKENHI-PROJECT-16K21330, KAKENHI-PROJECT-18K09248, KAKENHI-PROJECT-18K11542, KAKENHI-PROJECT-18K15304, KAKENHI-PUBLICLY-18H04908, KAKENHI-PROJECT-19H03429, KAKENHI-PROJECT-17K11268, KAKENHI-PROJECT-18K16757, KAKENHI-PROJECT-18K16759
[Journal Article] Kaempferol, a natural dietary flavonoid, suppresses 17beta-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer.2018
- Author(s)
  Chuwa Agapiti、Sone Kenbun、Oda Katsutoshi、Tanikawa Michihiro、Kukita Asako、Kojima Machiko、Oki Shinya、Fukuda Tomohiko、Takeuchi Makoto、Miyasaka Aki、Kashiyama Tomoko、Ikeda Yuji、Nagasaka Kazunori、Mori?Uchino Mayuyo、Matsumoto Yoko、Wada?Hiraike Osamu、Kuramoto Hiroyuki、Kawana Kei、Osuga Yutaka、Fujii Tomoyuki
- Journal Title
  
  Oncol Lett.
  
  Volume: 16 Pages: 6195-6201
- DOI
  10.3892/ol.2018.9340
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K11268, KAKENHI-PROJECT-18K09248, KAKENHI-PROJECT-18K09249, KAKENHI-PROJECT-16K21330, KAKENHI-PROJECT-17K16832

1. ODA Katsutoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. HIRAIKE Osamu

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
3. SONE Kembun

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
4. 浜本隆二

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. 金子修三

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. 田口歩

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 谷川道洋

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 樫山智子

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Miyasaka Aki 宮坂亞希

Research Projects

Research Products

Co-Researchers

Development of therapeutics targeting DNA damage repair pathway in uterine neoplasmsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Kaempferol, a natural dietary flavonoid, suppresses 17beta-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer.2018

Author(s)

Journal Title

DOI

Data Source

Miyasaka Aki 宮坂 亞希

Research Projects

Research Products

Co-Researchers

Development of therapeutics targeting DNA damage repair pathway in uterine neoplasmsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Kaempferol, a natural dietary flavonoid, suppresses 17beta-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer.2018

Author(s)

Journal Title

DOI

Data Source

Miyasaka Aki 宮坂亞希